Experimental autoimmune encephalomyelitis was induced and characterized as previously reported (31). Six- to 8-week-old C57/BL6 mice were immunized with MOG35-55 peptide (200 μg per mouse emulsified with CFA). Mice were also given pertussis toxin (200 ng per mouse) on day 0 and day 2 via tail vein injection. All mice were weighed and examined daily for clinical symptoms and assigned scores on a scale of 0–5 as follows: 0, no overt signs of disease; 1, limp tail; 2, limp tail and partial hindlimb paralysis; 3, complete hindlimb paralysis; 4, complete hindlimb and partial forelimb paralysis; 5, moribund state or death.
Mice were euthanized during the peak of disease. Following extensive transcardial perfusion with PBS, spinal cords and brains were removed from mice (tissues from 3 mice were pooled for each experiment) and pooled for mononuclear cell isolation. Briefly, tissues were incubated with collagenase D (300 μg/ml) and DNase I (20 μg/ml) in HBSS. After 45 min at 37 degrees, tissues were mechanically dissociated through a 40-μm strainer and washed with PBS. The resultant pellet was fractionated on a discontinuous percoll gradient. Infiltrating mononuclear cells were harvested from the interface, washed, counted, and cultured for 4 h in RPMI containing 10% FCS with PMA (10 ng/ml) and ionomycin (500 ng/ml) in presence of brefedlin A (10 μg/ml) for flow cytometry.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.